"10.1371_journal.pone.0013346","plos one","2010-10-13T00:00:00Z","Luc Dupuis; Odile Spreux-Varoquaux; Gilbert Bensimon; Philippe Jullien; Lucette Lacomblez; François Salachas; Gaëlle Bruneteau; Pierre-François Pradat; Jean-Philippe Loeffler; Vincent Meininger","INSERM U692, Strasbourg, France; Université de Strasbourg, Strasbourg, France; Faculté de Médecine Paris-Ile de France-Ouest, Paris, France; Université de Versailles Saint-Quentin-en-Yvelines, Versailles, France; Centre Hospitalier Versailles, Le Chesnay, France; Université Pierre et Marie Curie, Paris, France; UMR 7211, CNRS, Paris, France; Service de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière (AP-HP), Paris, France; Département des Maladies du Système Nerveux, Centre Référent Maladie Rare SLA Hôpital de la Pitié-Salpêtrière (AP-HP), Paris, France; INSERM U678, Paris, France","Conceived and designed the experiments: OSV GB VM. Performed the experiments: OSV. Analyzed the data: LD OSV GB VM. Contributed reagents/materials/analysis tools: OSV GB PJ LL FS GB PFP JPL VM. Wrote the paper: LD.","Pr Meininger received research support from Teva Pharma, GSK and Trophos. Dr. Lacomblez received research support from Trophos, Eisai, GSK, Novartis and Janssen-Cilag. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","10","Luc Dupuis","LD",10,TRUE,3,1,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
